Manchester Metropolitan University is working with a cutting edge technology firm to find a treatment for the hospital superbug MRSA which kills 5,000 patients each year.
MMU scientists and North West company Micap have spent two years researching antimicrobial agents to tackle the infection, known as a "superbug" for its resistance to antibiotics. The outcome is a blend of yeast and essential oils, including tea tree oil, which attacks and kills the bug.